Company intelligence / Profile preview

Cardia Labs

San Francisco, California, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Cardia Labs is a digital health company that develops an AI-powered platform for the early detection and management of cardiovascular diseases. The company leverages advanced machine learning algorithms to analyze physiological data from wearable devices and clinical inputs, providing users and healthcare providers with real-time insights into heart health. By focusing on proactive monitoring and early intervention, Cardia Labs aims to reduce the global burden of heart disease through accessible, data-driven technology. Their solutions are designed to identify early warning signs of conditions such as atrial fibrillation and heart failure, facilitating timely medical care.

Therapeutic areas: Cardiovascular
Modalities: Non-pharmacological therapyDeviceAI-driven diagnostics
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Cardia Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardia Labs.

Explore the full profile